Living systematic reviews in rehabilitation science can improve evidence-based healthcare

por Elbers, S., Wittink, H., Kaiser, U., Kleijnen, J., Pool, J., Köke, A., Smeets, R.
Publicado 2021

Ruptured endometrioma: main imaging findings

por Fonseca, Eduardo Kaiser U. N., Bastos, Bruna Bringel, Yamauchi, Fernando Ide, Baroni, Ronaldo Hueb
Publicado 2018

Thickening of the greater auricular nerve in leprosy: clinical correlation by ultrasound

por Fonseca, Eduardo Kaiser U. N., Nogueira, Felipe Melo, dos Santos, Sarah Simaan, Lerner, Tatiana Goberstein, Castro, Adham do Amaral e
Publicado 2018

Overuse of the hip external rotators: greater trochanter apophysitis in the karate kid

por Kubo, Rafael Seiji, Kihara Filho, Eduardo Noda, Fonseca, Eduardo Kaiser U. N., Castro, Adham do Amaral e, Santos, Durval do Carmo Barros
Publicado 2018

Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial

por Weiss, L., Karthaus, M., Riera-Knorrenschild, J., Kretzschmar, A., Welslau, M., Vehling-Kaiser, U., Pelz, H., Ettrich, T.J., Hess, J., Reisländer, T., Klein, A., Heinemann, V.
Publicado 2022

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

por Lordick, F, Lorenzen, S, Stollfuss, J, Vehling-Kaiser, U, Kullmann, F, Hentrich, M, Zumschlinge, R, Dietzfelbinger, H, Thoedtmann, J, Hennig, M, Seroneit, T, Bredenkamp, R, Duyster, J, Peschel, C
Publicado 2005

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial

por Huebner, G, Link, H, Kohne, C H, Stahl, M, Kretzschmar, A, Steinbach, S, Folprecht, G, Bernhard, H, Al-Batran, S E, Schoffski, P, Burkart, C, Kullmann, F, Otremba, B, Menges, M, Hoffmann, M, Kaiser, U, Aldaoud, A, Jahn, A
Publicado 2009

Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial

por Stintzing, S, Fischer von Weikersthal, L, Vehling-Kaiser, U, Stauch, M, Hass, H G, Dietzfelbinger, H, Oruzio, D, Klein, S, Zellmann, K, Decker, T, Schulze, M, Abenhardt, W, Puchtler, G, Kappauf, H, Mittermüller, J, Haberl, C, Giessen, C, Moosmann, N, Heinemann, V
Publicado 2011

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy:...

por von Einem, J. C., Heinemann, V., von Weikersthal, L. Fischer, Vehling-Kaiser, U., Stauch, M., Hass, H. G., Decker, T., Klein, S., Held, S., Jung, A., Kirchner, T., Haas, M., Holch, J., Michl, M., Aubele, P., Boeck, S., Schulz, C., Giessen, C., Stintzing, S., Modest, D. P.
Publicado 2014

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104

por Boeck, S, Jung, A, Laubender, R P, Neumann, J, Egg, R, Goritschan, C, Vehling-Kaiser, U, Winkelmann, C, Fischer von Weikersthal, L, Clemens, M R, Gauler, T C, Märten, A, Klein, S, Kojouharoff, G, Barner, M, Geissler, M, Greten, T F, Mansmann, U, Kirchner, T, Heinemann, V
Publicado 2013

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers

por Giustina, A., Uygur, M. M., Frara, S., Barkan, A., Biermasz, N. R., Chanson, P., Freda, P., Gadelha, M., Kaiser, U. B., Lamberts, S., Laws, E., Nachtigall, L. B., Popovic, V., Reincke, M., Strasburger, C., van der Lely, A. J., Wass, J. A. H., Melmed, S., Casanueva, F. F.
Publicado 2023